Guowei Cheng
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic Study.
Journal: Current cancer drug targets
Published: July 14, 2022
Prognostic value of circulating tumour DNA during post-radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma.
Journal: Clinical and translational medicine
Published: July 12, 2022
RS1 gene is a novel prognostic biomarker for lung adenocarcinoma.
Journal: Thoracic cancer
Published: March 29, 2022
Novel long noncoding RNA (lncRNA) panel as biomarkers for prognosis in lung squamous cell carcinoma via competitive endogenous RNA (ceRNA) network analysis.
Journal: Translational cancer research
Published: June 25, 2020
Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small cell lung cancer: a case report.
Journal: Annals of palliative medicine
Published: April 23, 2020
Silence of S1 RNA binding domain 1 represses cell growth and promotes apoptosis in human non-small cell lung cancer cells.
Journal: Translational lung cancer research
Published: February 04, 2020
Transcriptome alteration spectrum in rat lung induced by radiotherapy.
Journal: Scientific reports
Published: June 18, 2019
CHST15 promotes the proliferation of TE‑1 cells via multiple pathways in esophageal cancer.
Journal: Oncology reports
Published: May 29, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026